Global and China Hypertension and Heart Failure Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 95 pages | ID: GD11B90F170EEN
QYResearch

Abstracts

Global Hypertension and Heart Failure Treatment Scope and Market Size
Hypertension and Heart Failure Treatment market is segmented by Type, and by End Users. Players, stakeholders, and other participants in the global Hypertension and Heart Failure Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by End Users in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• Diuretics
• Beta Blockers
• Ace Inhibitors
• Alpha Blockers
• Others

Market segment by End Users, split into

• Men
• Women

Based on regional and country-level analysis, the Hypertension and Heart Failure Treatment market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Hypertension and Heart Failure Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Menarini Group
• Johnson & Johnson
• Lupin
• Boehringer Ingelheim
• Novartis
• Merck & Co
• AstraZeneca
• Pfizer, Inc
• Sanofi SA
• Dr. Reddy's Laboratories
• Daiichi Sankyo Company Limited

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Hypertension and Heart Failure Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Diuretics
  1.2.3 Beta Blockers
  1.2.4 Ace Inhibitors
  1.2.5 Alpha Blockers
  1.2.6 Others
1.3 Market by Application
  1.3.1 Global Hypertension and Heart Failure Treatment Market Share by End Users: 2020 VS 2026
  1.3.2 Men
  1.3.3 Women
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Hypertension and Heart Failure Treatment Market Perspective (2015-2026)
2.2 Global Hypertension and Heart Failure Treatment Growth Trends by Regions
  2.2.1 Hypertension and Heart Failure Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hypertension and Heart Failure Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Hypertension and Heart Failure Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hypertension and Heart Failure Treatment Players by Market Size
  3.1.1 Global Top Hypertension and Heart Failure Treatment Players by Revenue (2015-2020)
  3.1.2 Global Hypertension and Heart Failure Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Hypertension and Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypertension and Heart Failure Treatment Revenue
3.4 Global Hypertension and Heart Failure Treatment Market Concentration Ratio
  3.4.1 Global Hypertension and Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Hypertension and Heart Failure Treatment Revenue in 2019
3.5 Key Players Hypertension and Heart Failure Treatment Area Served
3.6 Key Players Hypertension and Heart Failure Treatment Product Solution and Service
3.7 Date of Enter into Hypertension and Heart Failure Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HYPERTENSION AND HEART FAILURE TREATMENT BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hypertension and Heart Failure Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypertension and Heart Failure Treatment Forecasted Market Size by Type (2021-2026)

5 HYPERTENSION AND HEART FAILURE TREATMENT BREAKDOWN DATA BY END USERS (2015-2026)

5.1 Global Hypertension and Heart Failure Treatment Historic Market Size by End Users (2015-2020)
5.2 Global Hypertension and Heart Failure Treatment Forecasted Market Size by End Users (2021-2026)

6 NORTH AMERICA

6.1 North America Hypertension and Heart Failure Treatment Market Size (2015-2026)
6.2 North America Hypertension and Heart Failure Treatment Market Size by Type (2015-2020)
6.3 North America Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020)
6.4 North America Hypertension and Heart Failure Treatment Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Hypertension and Heart Failure Treatment Market Size (2015-2026)
7.2 Europe Hypertension and Heart Failure Treatment Market Size by Type (2015-2020)
7.3 Europe Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020)
7.4 Europe Hypertension and Heart Failure Treatment Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Hypertension and Heart Failure Treatment Market Size (2015-2026)
8.2 China Hypertension and Heart Failure Treatment Market Size by Type (2015-2020)
8.3 China Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020)
8.4 China Hypertension and Heart Failure Treatment Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Hypertension and Heart Failure Treatment Market Size (2015-2026)
9.2 Japan Hypertension and Heart Failure Treatment Market Size by Type (2015-2020)
9.3 Japan Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020)
9.4 Japan Hypertension and Heart Failure Treatment Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Hypertension and Heart Failure Treatment Market Size (2015-2026)
10.2 Southeast Asia Hypertension and Heart Failure Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Hypertension and Heart Failure Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Hypertension and Heart Failure Treatment Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 Menarini Group
  11.1.1 Menarini Group Company Details
  11.1.2 Menarini Group Business Overview
  11.1.3 Menarini Group Hypertension and Heart Failure Treatment Introduction
  11.1.4 Menarini Group Revenue in Hypertension and Heart Failure Treatment Business (2015-2020))
  11.1.5 Menarini Group Recent Development
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Details
  11.2.2 Johnson & Johnson Business Overview
  11.2.3 Johnson & Johnson Hypertension and Heart Failure Treatment Introduction
  11.2.4 Johnson & Johnson Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.2.5 Johnson & Johnson Recent Development
11.3 Lupin
  11.3.1 Lupin Company Details
  11.3.2 Lupin Business Overview
  11.3.3 Lupin Hypertension and Heart Failure Treatment Introduction
  11.3.4 Lupin Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.3.5 Lupin Recent Development
11.4 Boehringer Ingelheim
  11.4.1 Boehringer Ingelheim Company Details
  11.4.2 Boehringer Ingelheim Business Overview
  11.4.3 Boehringer Ingelheim Hypertension and Heart Failure Treatment Introduction
  11.4.4 Boehringer Ingelheim Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.4.5 Boehringer Ingelheim Recent Development
11.5 Novartis
  11.5.1 Novartis Company Details
  11.5.2 Novartis Business Overview
  11.5.3 Novartis Hypertension and Heart Failure Treatment Introduction
  11.5.4 Novartis Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.5.5 Novartis Recent Development
11.6 Merck & Co
  11.6.1 Merck & Co Company Details
  11.6.2 Merck & Co Business Overview
  11.6.3 Merck & Co Hypertension and Heart Failure Treatment Introduction
  11.6.4 Merck & Co Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.6.5 Merck & Co Recent Development
11.7 AstraZeneca
  11.7.1 AstraZeneca Company Details
  11.7.2 AstraZeneca Business Overview
  11.7.3 AstraZeneca Hypertension and Heart Failure Treatment Introduction
  11.7.4 AstraZeneca Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.7.5 AstraZeneca Recent Development
11.8 Pfizer, Inc
  11.8.1 Pfizer, Inc Company Details
  11.8.2 Pfizer, Inc Business Overview
  11.8.3 Pfizer, Inc Hypertension and Heart Failure Treatment Introduction
  11.8.4 Pfizer, Inc Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.8.5 Pfizer, Inc Recent Development
11.9 Sanofi SA
  11.9.1 Sanofi SA Company Details
  11.9.2 Sanofi SA Business Overview
  11.9.3 Sanofi SA Hypertension and Heart Failure Treatment Introduction
  11.9.4 Sanofi SA Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.9.5 Sanofi SA Recent Development
11.10 Dr. Reddy's Laboratories
  11.10.1 Dr. Reddy's Laboratories Company Details
  11.10.2 Dr. Reddy's Laboratories Business Overview
  11.10.3 Dr. Reddy's Laboratories Hypertension and Heart Failure Treatment Introduction
  11.10.4 Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  11.10.5 Dr. Reddy's Laboratories Recent Development
11.11 Daiichi Sankyo Company Limited
  10.11.1 Daiichi Sankyo Company Limited Company Details
  10.11.2 Daiichi Sankyo Company Limited Business Overview
  10.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Treatment Introduction
  10.11.4 Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Treatment Business (2015-2020)
  10.11.5 Daiichi Sankyo Company Limited Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Hypertension and Heart Failure Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Diuretics
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Ace Inhibitors
Table 6. Key Players of Alpha Blockers
Table 7. Key Players of Others
Table 8. Global Hypertension and Heart Failure Treatment Market Size Growth by End Users (US$ Million): 2020 VS 2026
Table 9. Global Hypertension and Heart Failure Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Hypertension and Heart Failure Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Hypertension and Heart Failure Treatment Market Share by Regions (2015-2020)
Table 12. Global Hypertension and Heart Failure Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Hypertension and Heart Failure Treatment Market Share by Regions (2021-2026)
Table 14. Hypertension and Heart Failure Treatment Market Market Trends
Table 15. Hypertension and Heart Failure Treatment Market Drivers
Table 16. Hypertension and Heart Failure Treatment Market Challenges
Table 17. Hypertension and Heart Failure Treatment Market Restraints
Table 18. Global Hypertension and Heart Failure Treatment Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Hypertension and Heart Failure Treatment Market Share by Players (2015-2020)
Table 20. Global Top Hypertension and Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypertension and Heart Failure Treatment as of 2019)
Table 21. Global Hypertension and Heart Failure Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hypertension and Heart Failure Treatment Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hypertension and Heart Failure Treatment Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Hypertension and Heart Failure Treatment Market Size Share by Type (2015-2020)
Table 27. Global Hypertension and Heart Failure Treatment Revenue Market Share by Type (2021-2026)
Table 28. Global Hypertension and Heart Failure Treatment Market Size Share by End Users (2015-2020)
Table 29. Global Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 30. Global Hypertension and Heart Failure Treatment Market Size Share by End Users (2021-2026)
Table 31. North America Hypertension and Heart Failure Treatment Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Hypertension and Heart Failure Treatment Market Share by Type (2015-2020)
Table 33. North America Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 34. North America Hypertension and Heart Failure Treatment Market Share by End Users (2015-2020)
Table 35. North America Hypertension and Heart Failure Treatment Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Hypertension and Heart Failure Treatment Market Share by Country (2015-2020)
Table 37. Europe Hypertension and Heart Failure Treatment Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Hypertension and Heart Failure Treatment Market Share by Type (2015-2020)
Table 39. Europe Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 40. Europe Hypertension and Heart Failure Treatment Market Share by End Users (2015-2020)
Table 41. Europe Hypertension and Heart Failure Treatment Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Hypertension and Heart Failure Treatment Market Share by Country (2015-2020)
Table 43. China Hypertension and Heart Failure Treatment Market Size by Type (2015-2020) (US$ Million)
Table 44. China Hypertension and Heart Failure Treatment Market Share by Type (2015-2020)
Table 45. China Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 46. China Hypertension and Heart Failure Treatment Market Share by End Users (2015-2020)
Table 47. China Hypertension and Heart Failure Treatment Market Size by Region (US$ Million) (2015-2020)
Table 48. China Hypertension and Heart Failure Treatment Market Share by Region (2015-2020)
Table 49. Japan Hypertension and Heart Failure Treatment Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Hypertension and Heart Failure Treatment Market Share by Type (2015-2020)
Table 51. Japan Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 52. Japan Hypertension and Heart Failure Treatment Market Share by End Users (2015-2020)
Table 53. Japan Hypertension and Heart Failure Treatment Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Hypertension and Heart Failure Treatment Market Share by Country (2015-2020)
Table 55. Southeast Asia Hypertension and Heart Failure Treatment Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Hypertension and Heart Failure Treatment Market Share by Type (2015-2020)
Table 57. Southeast Asia Hypertension and Heart Failure Treatment Market Size by End Users (2015-2020) (US$ Million)
Table 58. Southeast Asia Hypertension and Heart Failure Treatment Market Share by End Users (2015-2020)
Table 59. Southeast Asia Hypertension and Heart Failure Treatment Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Hypertension and Heart Failure Treatment Market Share by Country (2015-2020)
Table 61. Menarini Group Company Details
Table 62. Menarini Group Business Overview
Table 63. Menarini Group Product
Table 64. Menarini Group Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 65. Menarini Group Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Product
Table 69. Johnson & Johnson Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Lupin Company Details
Table 72. Lupin Business Overview
Table 73. Lupin Product
Table 74. Lupin Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 75. Lupin Recent Development
Table 76. Boehringer Ingelheim Company Details
Table 77. Boehringer Ingelheim Business Overview
Table 78. Boehringer Ingelheim Product
Table 79. Boehringer Ingelheim Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 80. Boehringer Ingelheim Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 85. Novartis Recent Development
Table 86. Merck & Co Company Details
Table 87. Merck & Co Business Overview
Table 88. Merck & Co Product
Table 89. Merck & Co Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 90. Merck & Co Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Pfizer, Inc Business Overview
Table 97. Pfizer, Inc Product
Table 98. Pfizer, Inc Company Details
Table 99. Pfizer, Inc Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 100. Pfizer, Inc Recent Development
Table 101. Sanofi SA Company Details
Table 102. Sanofi SA Business Overview
Table 103. Sanofi SA Product
Table 104. Sanofi SA Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 105. Sanofi SA Recent Development
Table 106. Dr. Reddy's Laboratories Company Details
Table 107. Dr. Reddy's Laboratories Business Overview
Table 108. Dr. Reddy's Laboratories Product
Table 109. Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 110. Dr. Reddy's Laboratories Recent Development
Table 111. Daiichi Sankyo Company Limited Company Details
Table 112. Daiichi Sankyo Company Limited Business Overview
Table 113. Daiichi Sankyo Company Limited Product
Table 114. Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Treatment Business (2015-2020) (US$ Million)
Table 115. Daiichi Sankyo Company Limited Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hypertension and Heart Failure Treatment Market Share by Type: 2020 VS 2026
Figure 2. Diuretics Features
Figure 3. Beta Blockers Features
Figure 4. Ace Inhibitors Features
Figure 5. Alpha Blockers Features
Figure 6. Others Features
Figure 7. Global Hypertension and Heart Failure Treatment Market Share by End Users: 2020 VS 2026
Figure 8. Men Case Studies
Figure 9. Women Case Studies
Figure 10. Hypertension and Heart Failure Treatment Report Years Considered
Figure 11. Global Hypertension and Heart Failure Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Hypertension and Heart Failure Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Hypertension and Heart Failure Treatment Market Share by Regions (2021-2026)
Figure 14. Global Hypertension and Heart Failure Treatment Market Share by Players in 2019
Figure 15. Global Top Hypertension and Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypertension and Heart Failure Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Hypertension and Heart Failure Treatment Revenue in 2019
Figure 17. North America Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Hypertension and Heart Failure Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Menarini Group Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 45. Johnson & Johnson Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 46. Lupin Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 48. Novartis Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 49. Merck & Co Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 50. AstraZeneca Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 51. Pfizer, Inc Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 52. Sanofi SA Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 54. Daiichi Sankyo Company Limited Revenue Growth Rate in Hypertension and Heart Failure Treatment Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed